1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial). (September 2015) - Steger, G.G.; Dominguez, A.; Dobrovolskaya, N.; Giotta, F.; Tubiana-Mathieu, N.; Ardizzoia, A.; Blasinska, M.; Espinosa, E.; Landreau, P.; Villanova, G.